Research summary ·
Helicobacter pylori eradication for immune thrombocytopenia reduces non-response and raises platelet counts: Meta-analysis of randomized trials.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This study looked at people with immune thrombocytopenia, or ITP. H. pylori has been tied to ITP in past work. The team pooled the results of 8 trials. In each trial, people were put into groups by chance. One group got treatment to clear H. pylori. The other group served as a control. In total, 297 people took part, in Asia and Latin America.
What they found
People who had the treatment were less likely to show no or little response. Their platelet counts also rose more by about 6 months. Full response seemed more common, but this could be chance. Partial response and overall response did not clearly change. Relapse at 1 year seemed lower, but this was not certain. Checks that left out one trial at a time gave the same picture.
What it means for patients
The authors say clearing H. pylori was linked to fewer people with no response. It was also linked to a larger rise in platelets. They see the drop in no response as the firmest finding. Effects on full response and relapse are still unclear.
Why it is not certain yet
Only 8 trials with 297 people in total were included. Signs of small-study bias were found for full and overall response. So those results may look better than they really are. Platelet results varied a lot between trials. The authors say larger trials are needed. These should show who gains most and how long effects last.
Source
Helicobacter pylori eradication for immune thrombocytopenia reduces non-response and raises platelet counts: Meta-analysis of randomized trials.
PubMed · PMID 42911235We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Immune thrombocytopenia (ITP) publications